key: cord-0780115-6m5n6iai
authors: Mongula, J. E.; Frenken, M. W. E.; van Lijnschoten, G.; Arents, N. L. A.; de Wit‐Zuurendonk, L. D.; Schimmel‐de Kok, A. P. A.; van Runnard Heimel, P. J.; Porath, M. M.; Goossens, S. M. T. A.
title: COVID‐19 during pregnancy: non‐reassuring fetal heart rate, placental pathology and coagulopathy
date: 2020-08-27
journal: Ultrasound Obstet Gynecol
DOI: 10.1002/uog.22189
sha: 70739bafd26b2f4877e89f879123a13a5ddc3fc6
doc_id: 780115
cord_uid: 6m5n6iai

A case of a pregnant woman suffering from COVID‐19 is presented, who developed coagulopathy in the absence of severe clinical symptoms. The PCR test of the vaginal swab was positive on SARS‐CoV‐2 RNA, suggesting a possibility of perinatal transmission. A cesarean delivery was done because of a non‐reassuring fetal heart rate; the placenta showed increased perivillous fibrin deposition and intervillositis. Moreover, placental infection with SARS‐CoV‐2 was demonstrated by placental immunostaining. We suggest a relation between placental fibrin deposition and both chronic and acute intervillositis, non‐reassuring fetal heart rate and coagulopathy in pregnant women with COVID‐19. This article is protected by copyright. All rights reserved.

A 27-year old woman (gravida 2, para 1) presented to the obstetrical outpatient clinic at a gestational age (GA) of 31 +4 weeks, with complaints of headache, malaise, coughing, shortness of breath since ten days, fever and decreased fetal movements. She had a history of well-controlled type 1 diabetes with low-dose insulin, and pre-eclampsia in her previous pregnancy. She used prophylactic acetylsalicylic acid 1dd 80 mg. Her Body Mass Index was 22.4 kg/m 2 .

Her vital signs were normal; respiratory rate 15 breaths per minute, peripheral oxygen saturation (SpO2) 98%, blood pressure (BP) 142/76 mmHg, heart rate (HR) 105 beats per minute (bpm) and temperature 37.6 °C. The cardiotocography (CTG) showed fetal tachycardia of 165 bpm, but no additional abnormalities. The estimated fetal weight (2051 grams, 78 th percentile) and the amount of amniotic fluid were normal. Her laboratory results showed signs of infection (Table 1) .

She was admitted for fetal and maternal monitoring and cared for in isolation. COVID-19 was confirmed by a positive nasopharyngeal SARS-CoV-2 RNA PCR test, which was done using primers and probes as described by Corman et al. 1 At a GA of 31 +5 , despite absence of clinical symptoms and normal vital signs, she developed thrombocytopenia, anemia and increased LD and ALT. HELLP syndrome (Hemolysis, Elevated Liver enzymes and Low Platelets) was rejected due to normal urate and haptoglobin levels. Disseminated intravascular coagulation (DIC) was suspected. A (partial) placental abruption as the cause of DIC was deemed unlikely because of absence of symptoms, and normal clinical examination, CTG and placental ultrasound evaluation. There were no signs of any bacterial superinfection. Corticosteroids were administered. The PCR This article is protected by copyright. All rights reserved. This article is protected by copyright. All rights reserved.

At a GA of 32 +1 weeks, the CTG showed a decrease in variability and an incidental deceleration. The patient did not report any symptoms and had normal vital signs. Ultrasound examination showed oligohydramnios. The umbilical arterial Doppler was normal (pulsatility index: 0.8). Premature preterm rupture of membranes was suspected based on a fern-like pattern in a vaginal swab.

An emergency cesarean delivery (CD) was performed. The total blood loss was 1370cc.

Three units of FFP, two grams of Fibrinogen, and two units of red blood cells were administered. The patient had a swift recovery and was discharged from the hospital two days postoperatively. This article is protected by copyright. All rights reserved. This article is protected by copyright. All rights reserved.

with SARS-CoV-2, it could be suggested that perinatal transmission is possible. In the abovementioned case, premature preterm rupture of membranes was diagnosed prior to CD.

The neonate may thus have been exposed to SARS-CoV-2 RNA present in the vagina. Signs of fetal distress in pregnant women with COVID-19 have been reported 3 , without clear cause of distress. We describe a placenta with increased perivillous fibrin depositions and chronic and acute intervillositis in a woman with COVID-19. Fibrin depositions and chronic intervillositis may coexist. 7 In the presence of acute intervillositis, however, this has only been described once before, namely in the first described case of proven transplacental transmission of SARS-CoV-2. 6 In that case, maternal thrombocytopenia and prolonged APTT, followed by non-reassuring fetal heart rate and an emergency CD, were noted as well.

This article is protected by copyright. All rights reserved. 6 A pathologic immune reaction has been proposed as reason for extensive perivillous fibrin depositions and chronic intervillositis, whilst a relationship with viral infections in pregnancy has only been described sporadically. 8,9 Extensive fibrin depositions are associated with adverse obstetrical outcomes 10 and have also been linked to coagulation disorders 11 , corresponding with the abovementioned case. The acute placental intervillous pathologies and especially the extensive fibrin depositions, possibly causing a non-reassuring fetal heart rate tracing, might be related to maternal illness (Diabetes, COVID-19 and possible DIC).

Due to pre-existing diabetes, our patient might have been more susceptible for a more severe course.

Literature on COVID-19 in a non-pregnant population suggest a possible prothrombogenic component associated with COVID-19. 12 Also, COVID-19 can be associated with coagulation disorders (COVID-19 associated coagulation disorder, CAC). It is suggested that this coagulopathy may be distinguished from other coagulopathies by a pre-dominant increase in D-dimer and other fibrinogen degradation products. The features of DIC and CAC may however partly overlap. 13 COVID-19-associated coagulopathy was not a described entity at the time of presentation early in the COVID-19 pandemic.

In non-pregnant COVID-19 patients, it is suggested that fibrin deposition in the pulmonary microvasculature is one of the causes of more severe ARDS in some patients. 14 A similar pathological process caused by COVID-19 might occur in the placenta, leading to COVID-19associated coagulopathy and a non-reassuring fetal heart rate. This article is protected by copyright. All rights reserved. 

Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR

Intrauterine vertical transmission of SARS-CoV-2: what we know so far

Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records

Pregnancy with new coronavirus infection: clinical characteristics and placental pathological analysis of three cases

A Case Report of Neonatal 2019 Coronavirus Disease in China

Transplacental transmission of SARS-CoV-2 infection

Chronic intervillositis of unknown etiology (CIUE): Relation between placental lesions and perinatal outcome

This article is protected by copyright. All rights reserved. This article is protected by copyright. All rights reserved.Accepted Article